drugset
drugset / Trial / NCT03425253

Sequential Treatment With BELKYRA® Then Juvéderm® VOLUMA™ With Lidocaine for Overall Improvement in Jawline Contour

NCT03425253 ↗

Phase 4 Completed 58 enrolled Allergan
NaSingle-groupOpen-labelTreatment

Summary

This study has been designed to evaluate the safety and effectiveness of sequential treatment with BELKYRA® (for the treatment of convexity and fullness associated with submental fat) and VOLUMA™ (to restore volume along the mandibular border) to enhance the overall contour of the jawline.

Timeline

Start
2018-02-02
Primary completion
2019-12-05
Completion
2019-12-05

Drugs

EvaluationDrugModalityDoseRoute
Subject BELKYRA Unknown — Subcutaneous

Indications

No indication recorded.